Diarrhea News and Research

Latest Diarrhea News and Research

Other types of E. coli shouldn't be ignored

While many of us are worried about E. coli 0157 in our food supply, a pre-harvest food safety expert at Kansas State University cautions that other types of E. coli shouldn't go ignored.

27 Feb 2008

Mosquito bourne diseases cause concern in three areas of Australia

Australian Health officials have issued public health warnings about mosquito bourne diseases in three areas.

25 Feb 2008

Alternative treatment method offers effective way to treat Crohn's disease

An international research study, published in The Lancet, has thrown into question the current method of treating Crohn's disease - opening the door to a safer and more effective treatment option for sufferers of the chronic disease.

22 Feb 2008

US advisory committee recommends approval of Rotarix

The US Advisory Committee on Vaccines and Related Biological Products issued a positive recommendation today on the use of rotavirus vaccines, potentially bringing greater protection to children in the US from this common and sometimes fatal cause of severe diarrhea.

21 Feb 2008

Sanitation paper shortlisted for Lancet Paper of the Year

A paper reporting on two cohort studies which looked at the effect of a city-wide sanitation programme on rates of childhood diarrhoea in northeast Brazil has been shortlisted for the Lancet Paper of the Year Award 2007.

18 Feb 2008

Scorpion venom may hold key to controlling cystic fibrosis

Researchers have discovered a peptide in scorpion venom that may hold the key to understanding and controlling cystic fibrosis and other secretory diseases.

17 Feb 2008

Stomach flu vaccine possibility

Every year, millions of people are infected with noroviruses - commonly called "stomach flu" - often resulting in up to 72 hours of vomiting and diarrhea.

14 Feb 2008

Probiotics help keep elite athletes fit and well

According to the latest Australian research the immune system of long-distance runners was enhanced by probiotics - dietary supplements containing potentially beneficial bacteria or yeasts.

13 Feb 2008

Amantadine and rimantadine for influenza A in children and the elderly

The antiviral drug amantadine can prevent some cases of influenza in children, and the related medication rimantadine can reduce fever in youngsters who have the flu, according to a new review of evidence.

8 Feb 2008

Lithium slows ALS progression

Daily doses of lithium, a drug used to treat bipolar disorder, have been found to delay progression of amyotrophic lateral sclerosis (ALS) in an Italian study of 44 people with the disease.

4 Feb 2008

Zinc supplementation helps diarrhea symptoms

Diarrhea is a major health problem, especially in the developing world. It is estimated that diarrheal disease is responsible for roughly 21 percent of all deaths in children younger than 5 worldwide.

4 Feb 2008

Handwashing can reduce diarrhea episodes by about one third

Both in institutions and in communities, interventions that promote hand washing lead to significant reductions in the incidence of diarrhoea.

24 Jan 2008

Scientists render Ebola harmless in the laboratory

Scientists in the United States say that they have found a way to make the lethal Ebola virus harmless in the laboratory.

23 Jan 2008

Researchers identify a means of controlling a parasite that kills and eats human cells

Researchers from the University of Virginia and the University of Vermont have discovered a means of inhibiting one of the world's most voracious parasites.

21 Jan 2008

Listeria at a milk processing plant to blame for 3 deaths

Public health officials in the U.S. investigating an outbreak of listeria have found 16 samples of listeria bacteria at a milk processing plant.

20 Jan 2008

Latest U.S. food scare E. coli and 188,000 pounds of ground beef

In the latest food scare in the United States fears of contamination with the Escherichia coli (E. coli) bacteria has prompted the recall of more than 188,000 pounds of ground beef products.

16 Jan 2008

FDA approves Tysabri to treat Crohn's disease

The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.

14 Jan 2008

Chewing too much gum linked to excessive weight loss

German scientists have revealed a link between chewing too much gum and excessive weight loss.

14 Jan 2008

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

11 Jan 2008

The drug sirolimus shrinks tumors, improves lung function

The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with who would otherwise face surgery.

10 Jan 2008